Biotech and Pharmaceuticals
Novo Nordisk shares soar 5% on promising fat reduction demo final results Eli Lilly dips
Jonathan Raa | Nurphoto | Getty Photos Novo Nordisk shares climbed 5% on Thursday early morning, in accordance to LSEG details, hitting a fresh new record highs right after the Danish pharmaceutical big claimed positive early demo data for a new experimental fat loss drug. The company told an investor assembly that the Section I […]
Read More
Biden says Medicare should negotiate prices for at least 50 drugs each year, up from a target of 20
US President Joe Biden speaks during an event at the National Institutes of Health (NIH) in Bethesda, Maryland, US, on Thursday, Dec. 14 2023. Chris Kleponis | Bloomberg | Getty Images President Joe Biden on Wednesday said the federal Medicare program should negotiate prices for at least 50 prescription drugs each year, up from the […]
Read More
Healthy Returns: What to know about CDC’s new Covid recommendations
A general view of the Centers for Disease Control and Prevention (CDC) headquarters in Atlanta, Georgia. Tami Chappell | Reuters Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! The Centers for Disease Control and Prevention announced two major new Covid recommendations last week. The […]
Read More
Novo Nordisk's diabetes drug Ozempic slashed the risk of kidney disease progression in trial
This picture taken on October 23, 2023, shows Ozempic medication boxes, an injectable antidiabetic drug, in a pharmacy in Riedisheim, eastern France. Sebastien Bozon | Afp | Getty Images Novo Nordisk‘s blockbuster drug Ozempic cut the risk of kidney disease progression and related health complications in diabetic patients, according to initial late-stage trial results released […]
Read More
We're in a 'boomer renaissance,' top hedge fund manager says — naming sectors and stocks to play it
Top hedge fund manager David Neuhauser says the world is in a “boomer renaissance” and investors should be betting big on certain sectors that play the theme. The world is aging rapidly, and sectors such as tourism, health care and biotech will benefit from that, according to Neuhauser, who is founder and chief investment officer […]
Read More
Viking Therapeutics emerges as a strong weight loss drug player — or takeover target
Cr | Istock | Getty Images Biotech company Viking Therapeutics has emerged as a strong potential entrant — or takeover target — in the budding weight loss drug market. Viking is just one of several companies racing to join the growing space. Some analysts say the market could be worth $100 billion by the end […]
Read More
Judge rejects AstraZeneca’s challenge to Medicare drug price negotiations
Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services building in Washington, D.C., on Oct. 6, 2022. Anna Moneymaker | Getty Images A federal judge on Friday rejected AstraZeneca‘s legal challenge to Medicare’s new power to negotiate the prices of certain costly prescription drugs with […]
Read More
CVS and Walgreens to start selling abortion pill mifepristone this month
A container holding boxes of mifepristone, the first medication in a medical abortion, are prepared for patients at Alamo Women’s Clinic in Carbondale, Illinois, on April 20, 2023. Evelyn Hockstein | Reuters CVS and Walgreens will start selling the abortion pill mifepristone this month at certain pharmacy locations in states where it is legal to […]
Read More
Musk's Neuralink mind implant organization cited by Fda around animal lab difficulties
Dilara Irem Sancar | Anadolu | Getty Visuals U.S. Food and Drug Administration inspectors uncovered troubles with history preserving and excellent controls for animal experiments at Elon Musk’s Neuralink, much less than a thirty day period right after the startup claimed it was cleared to take a look at its mind implants in people, according […]
Read More
Pfizer RSV vaccine maintains protection in older adults over two seasons in trial
Respiratory syncytial virus vial. Manjurul | Istock | Getty Images Pfizer‘s vaccine against respiratory syncytial virus maintained protection for older adults across two full seasons of the disease in an ongoing late-stage clinical trial, the company announced Thursday. The shot’s efficacy declined slightly compared with the levels of protection after one RSV season, but the […]
Read More